Lower prevalence of tuberculosis infection in BCG vaccinees: A cross-sectional study in adult prison inmates

Thorax

Volumn 68, Issue 3, 2013, Pages 263-268

  Chan, Pei Chun ^a,b,c   Yang, Chin Hui ^a   Chang, Luan Yin ^c   Wang, Kwei Feng ^a   Kuo, Yi Chen ^d   Lin, Chou Jui ^e   Lee, Shih Wei ^e   Hsueh, Po Ren ^c   Fang, Chi Tai ^b,c   Huang, Li Min ^c  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d Guishan Township Health Station   (Taiwan)

^e TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADULT; ADULTHOOD; AGE DISTRIBUTION; AGED; ARTICLE; BCG VACCINATION; CROSS-SECTIONAL STUDY; HEALTH CARE POLICY; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PRISON; PRISONER; PROTECTION; REFERENCE VALUE; SCAR; SCREENING TEST; TAIWAN;

EID: 84873739481     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202208     Document Type: Article

References (39)

1. Fine PEM, Carneiro IAM, Milstein JB, et al. Issues relating to the use of BCG in immunization programs. Geneva: World Health Organization, 1999.
2. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-8.
3. Colditz GA, Berkey CS, Mosteller F, et al The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995;96:29-35.
4. World Health Organization. BCG vaccine WHO positional paper. Wkly Epidemiol Rec 2004;79:25-40.
5. Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska natives a 60-year follow-up study. JAMA 2004;291:2086-91.
6. Barreto ML, Cunha SS, Pereira SM, et al. Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil. Int J Tuberc Lung Dis 2005;9:1171-3.
7. Hart PD, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. BMJ 1977;2:293-5.
8. Comstock GW, Webster RG. Tuberculosis studies in Muscogee County, Georgia, VII. A twenty year evaluation of BCG vaccination in school population. Am Rev Respir Dis 1969;100:839-45.
9. Tuberculosis Prevention Trial, Madras. Trial of BCG vaccines in south India for tuberculosis prevention: first report. Bull World Health Organ 1979;57:819-27.
10. Smith D, Wiegeshaus E, Balasubramanian V. An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial. Clin Infect Dis 2000;31 (Suppl 3):S77-80.
11. Dietrich J, Doherty TM. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. APMIS 2009;117:440-57.
12. Russell DG, Barry CE, Flynn JL. Tuberculosis: what we don't know can, and does, hurt us. Science 2010;328:852-6.
13. Diel R, Goletti D, Ferrara G, et al Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011;37:88-99.
14. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-84.
15. Soysal A, Millington KA, Bakir M, et al Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005;366:1443-51.
16. Eriksen J, Chow JY, Mellis V, et al. Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? Thorax 2010;65:1067-71.
17. Provincial Chronic Disease Control Bureau. A review of the tuberculosis control program in Taiwan, 1949-1989: Chronological Development of the Program, BCG vaccination. Taipei, Taiwan: Provincial Chronic Disease Control Bureau, 1991:4-37.
18. World Health Organization. Statement on BCG revaccination for the prevention of tuberculosis. Wkly Epidemiol Rec 1995;70:229-36.
19. Chan PC, Yang CH, Chang LY, et al. Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial. Int J Tuberc Lung Dis 2012;16:633-8.
20. Chiang CY, Hsu CJ, Hsu PK, et al. Pulmonary tuberculosis in the Taiwanese prison population. J Formos Med Assoc 2002;101:537-41.
21. Centers for Disease Control, Department of Health. Taiwan guidelines for TB diagnosis & treatment. 2nd edn. Taipei, Taiwan: CDC, 2006.
22. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:2060-7.
23. Yoshiyama T, Harada N, Higuchi K, et al. Use of the QuantiFERON-TB Gold test for screening tuberculosis contacts and predicting active disease. Int J Tuberc Lung Dis 2010;14:819-27.
24. Diel R, Loddenkemper R, Niemann S, et al. Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011;183:88-95.
25. Costa JT, Rui S, Raul S, et al. Serial testing with the interferon-gamma release assay in Portuguese healthcare workers. Int Arch Occup Environ Health 2011;84:461-9.
26. Ringshausen FC, Schablon A, Nienhaus A. Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol 2012;7:6.
27. Karonga Prevention Trial Group. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996;348:17-24.
28. Leung CC, Tam CM, Chan SL, et al. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis 2001;5:717-23.
29. Rodrigues LC, Pereira SM, Cunha SS, et al Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 2005;366:1290-5.
30. Barreto ML, Pereira SM, Pilger D, et al Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. Vaccine 2011;29:4875-7.
31. Narayanan PR. Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India. Indian J Med Res 2006;123:119-24.
32. Kremer K, van-der-Werf MJ, Au BK, et al Vaccine induced immunity circumvented by typical mycobacterium tuberculosis Beijing strains. Emerg Infect Dis 2009;15:335-9.
33. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756-61.
34. Harada N, Nakajima Y, Higuchi K, et al. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006;27:442-8.
35. Choi JC, Shin JW, Kim JY, et al. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 2008;133:1415-20.
36. Nienhaus A, Schablon A, Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection - analysis of discordant results, when compared to the tuberculin skin test. PLoS ONE 2008;3:e2665.
37. O'Neal S, Hedberg K, Markum A, et al. Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers. Int J Tuberc Lung Dis 2009;13:662-4.
38. Tuberculosis Prevention Trial, Madras. Trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res 1980;72:S1-74.
39. Beskow R, Bleiker M, Dahlstrom G, et al. Sensitivity to tuberculin in Swedish schoolboys vaccinated with BCG at birth. Bull Int Union Tuberc 1980;55:101-6.